Cellectar Biosciences Q3'26 Earnings Preview: EPS Estimated at $(0.56)
Cellectar Biosciences is expected to report Q3'26 results on November 10 before the market opens. Revenue is estimated at $0, with EPS expected at $(0.56).
CLRB (Cellectar Biosciences, Inc.) is set to announce its Q3'26 results on November 10, before the market opens. The earnings are expected to be disclosed at 9:30 AM ET (2:30 PM UTC).For Q3'26, revenue estimate is 0 USD with EPS (earnings per share) anticipated at (0.56) USD. Learn more details at…